Walleye Capital LLC Crinetics Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

A detailed history of Walleye Capital LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 4,300 shares of CRNX stock, worth $235,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,300

Previous 34,900 87.68%

Holding current value

$235,296

Previous $1.56 Million 85.99%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$43.83 - $54.98 $4.13 Million - $5.18 Million	-94,274 Reduced 29.91%	220,946 $11.3 Million
Q2 2024 Aug 14, 2024	BUY	$42.12 - $51.91 $3.11 Million - $3.83 Million	73,858 Added 30.6%	315,220 $14.1 Million
Q1 2024 May 15, 2024	SELL	$34.76 - $46.81 $963,755 - $1.3 Million	-27,726 Reduced 10.3%	241,362 $11.3 Million
Q4 2023 Feb 14, 2024	SELL	$25.62 - $37.07 $4.25 Million - $6.15 Million	-165,822 Reduced 38.13%	269,088 $9.57 Million
Q3 2023 Nov 14, 2023	BUY	$15.97 - $30.59 $1.94 Million - $3.71 Million	121,312 Added 38.68%	434,910 $12.9 Million
Q2 2023 Aug 14, 2023	SELL	$15.73 - $23.6 $1.89 Million - $2.83 Million	-120,097 Reduced 27.69%	313,598 $5.65 Million
Q1 2023 May 15, 2023	BUY	$15.31 - $21.1 $430,762 - $593,669	28,136 Added 6.94%	433,695 $6.97 Million
Q4 2022 Feb 14, 2023	BUY	$15.49 - $19.05 $2.41 Million - $2.96 Million	155,545 Added 62.21%	405,559 $7.42 Million
Q3 2022 Nov 14, 2022	BUY	$18.11 - $22.37 $1.74 Million - $2.15 Million	95,922 Added 62.25%	250,014 $4.91 Million
Q2 2022 Aug 08, 2022	SELL	$16.49 - $27.64 $485,646 - $814,025	-29,451 Reduced 16.05%	154,092 $2.87 Million
Q1 2022 May 16, 2022	BUY	$17.15 - $28.31 $1.65 Million - $2.72 Million	95,935 Added 109.5%	183,543 $4.03 Million
Q4 2021 Mar 03, 2022	BUY	$19.35 - $28.41 $1.7 Million - $2.49 Million	87,608 New	87,608 $2.49 Million
Q1 2021 May 17, 2021	SELL	$13.3 - $17.55 $160,930 - $212,355	-12,100 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.08 - $17.46 $146,168 - $211,266	12,100 New	12,100 $171,000

Others Institutions Holding CRNX

# of Institutions

241

Shares Held

79.6M

Call Options Held

23.3K

Put Options Held

44.3K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.94B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Crinetics Pharmaceuticals, Inc. Transaction History